Alzamend Neuro (ALZN) Assets Average (2021 - 2026)

Alzamend Neuro has disclosed Assets Average across 6 years of filings, most recently posting $3.1 million for Q2 2026.

• In Q2 2026, Assets Average fell 30.27% year-over-year to $3.1 million; the TTM figure through Apr 2026 stood at $3.1 million (down 30.27% YoY), while the FY2026 annual figure was $3.3 million, up 27.66% from the prior year.
• Assets Average came in at $3.1 million for Q2 2026 at Alzamend Neuro, down from $4.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $13.5 million in Q2 2022 to a low of $707112.0 in Q2 2024.
• Average Assets Average over 5 years is $6.0 million, with a median of $4.6 million recorded in 2025.
• Year-over-year, Assets Average plunged 90.67% in 2024 and jumped 520.74% in 2025.
• Over 5 years, Assets Average stood at $11.3 million in 2022, then plunged by 84.04% to $1.8 million in 2023, then jumped by 84.89% to $3.3 million in 2024, then surged by 71.0% to $5.7 million in 2025, then tumbled by 46.39% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $3.1 million in Q2 2026, $4.6 million in Q1 2026, and $5.7 million in Q4 2025.